Dublin-based PlasmaBound, a company that has developed Controlled Polymer Ablation (CPA), announced on Friday that it raised €750K in funding from Business Venture Partners (BVP) in December.
The funding was added to a prior 2022 raise with Act Venture Capital, Atlantic Bridge, and Enterprise Ireland, bringing the total amount raised in 2022 to €3.1M.